The market is fragmented, featuring the presence of both industry and non-industry players that are involved in providing proteome profiling services for various applications, claims Roots Analysis

stefanwill

191
views

The market is fragmented, featuring the presence of both industry and non-industry players that are involved in providing proteome profiling services for various applications, claims Roots Analysis

With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive, and accurate quantification methods to analyze clinical specimens. As a result, proteome profiling has become an indispensable part of modern drug discovery and development process, as well as disease diagnosis.

To order this 290+ page report, which features 50+ figuresand 100+ tables, please visit this link

The USD 16 billion(by 2030) financial opportunity within the proteome profiling services markethas been analyzed across the following segments:

§ ApplicationArea

§ DrugDiscovery

§ Disease Diagnosis

§ Others

§ Typeof Sponsor(s)

§ Contract Research Organizations

§ Pharmaceutical Companies

§ Research and Academic Institutes

§ KeyGeographical Regions

§ NorthAmerica

§ Europe

§ AsiaPacific

§ Restof the World

The Proteome ProfilingServices Market, 2020-2030 report features the following companies, which weidentified to be key players in this domain:

§ Biognosys

§ BGI

§ Bioproximity

§ Cell SignalingTechnology

§ Creative Biolabs

§ Creative Proteomics

§ Cytomics

§ i-DNA Biotechnology

§ NMI TT Pharmaservices

§ Poochon Scientific

§ ProteomicsInternational

§ Proteome Factory